Skip to content
value.today

Labcyte Inc

Total raised
$11 M
2 rounds on record
Latest round
$5 M
Dec 2016
First round on record
Dec 2012
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Labcyte Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2016$5 MNo. 2$2 to $10 million

Labcyte Inc: Raise no. 2, Dec 2016

Investors in this round

1 investor had bought by the notice of Jan 9, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Fischer-Colbrie · Executive Officer, Director
  • Richard Ellson · Executive Officer, Director
  • Tammy Cameron · Executive Officer
  • Craig Taylor · Director
  • Joe Keegan · Director
  • Joseph Smith · Director
  • Sandra Panem · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tammy Cameron, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 9, 2017. Read the notice at the SEC.

equitySEC
Dec 2012$6 MNo. 1$2 to $10 million

Labcyte Inc: Raise no. 1, Dec 2012

Investors in this round

18 investors had bought by the notice of Sep 20, 2013: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Fischer-Colbrie · Executive Officer, Director
  • Tammy L. Cameron · Executive Officer
  • Craig C. Taylor · Director
  • Jonathan D. MacQuitty · Director
  • Joseph D. Keegan · Director
  • Joseph H. Smith · Director
  • Richard L. Ellson · Director
  • Sandra D. Panem · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tammy L. Cameron, Vice President - Finance. Source: SEC Form D and 1 amendment, newest notice filed Sep 20, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Labcyte Inc chose not to state its revenue in its newest notice of a funding round (Jan 2017).

    SEC Form D · Jan 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2017

That is all the official record says: Labcyte Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Labcyte Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 18 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Labcyte Inc
NameRoleNamed in
Mark Fischer-ColbrieExecutive officerJan 2017
Richard EllsonExecutive officerJan 2017
Tammy CameronExecutive officerJan 2017
Tammy L. CameronExecutive officerSep 2013
Craig TaylorDirectorJan 2017
Joe KeeganDirectorJan 2017
Joseph SmithDirectorJan 2017
Mark Fischer-ColbrieDirectorJan 2017
Richard EllsonDirectorJan 2017
Sandra PanemDirectorJan 2017
Craig C. TaylorDirectorSep 2013
Jonathan D. MacQuittyDirectorSep 2013
Joseph D. KeeganDirectorSep 2013
Joseph H. SmithDirectorSep 2013
Richard L. EllsonDirectorSep 2013
Sandra D. PanemDirectorSep 2013
Andre J. MarionDirectorJan 2013
Elaine J. HeronDirectorJan 2013
Jonathan J. MacQuittyDirectorJan 2013
Sandra J. PanemDirectorJan 2013